Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Medicare, Eli Lilly and sleep apnea
Eli Lilly's obesity drug gets Medicare coverage for sleep apnea
Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, broadening access to the blockbuster weight-loss treatment. The Wednesday statement from the Centers for Medicare & Medicaid Services comes after Zepbound in December became the first drug approved in the U.
Lilly Wins Medicare Coverage for Zepbound in Sleep Apnea
According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to secure CMS coverage for obesity drugs.
Medicare Expands Coverage of Eli Lilly’s Weight-Loss Drug
Eli Lilly’s popular anti-obesity drug Zepbound could get a sales boost after the U.S. Medicare program decided to pay for its use to treat sleep apnea. The Centers f
CMS confirms to CNBC Medicare plans can now cover Zepbound for sleep apnea
The Centers for Medicare & Medicaid Services confirmed to CNBC that Medicare drug plans can now cover Eli Lilly’s (LLY) obesity drug
57m
on MSN
Exclusive: Arianna Huffington’s Thrive Global inks novel partnership with pharma giant Eli Lilly
Arianna Huffington's Thrive Global partners with Zepbound-maker Eli Lilly to share content on healthy habits where patients ...
3h
on MSN
Flynn: Eli Lilly could capture a significant part of a $100 billion market with Zepbound.
Terence Flynn, Biotech Analyst at Morgan Stanley, discusses Eli Lilly's recent stock boost and its designation as Morgan ...
FierceBiotech
1h
Lilly crafts deal for up to 5 new ALS antibodies with UK biotech Alchemab
Under the terms of the deal, Alchemab and Lilly will work together on up to five new antibodies, according to a Jan. 9 ...
2h
US pharma major Eli Lilly to establish second Indian GCC in Hyderabad
The GCC, to be known as the Lilly Capability Centre India (LCCI), will be the company’s second centre in the country, ...
STAT
3d
Eli Lilly seeks to join lawsuit on compounded drugs
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
2d
Eli Lilly's Options: A Look at What the Big Money is Thinking
Investors with a lot of money to spend have taken a bullish stance on Eli Lilly LLY. And retail traders should know. We ...
1h
Thrive Global Works with Eli Lilly and Company to Offer Healthy Behaviors Tools and Resources to Improve Health Outcomes
Thrive Global announced today it is working with Eli Lilly and Company to embed behavior change tools and resources onto LillyDirect and into traditional Lilly consumer channels in order to complement ...
2d
Lilly Pulitzer Just Marked Down Some Of Our Favorite Styles By Up To 70%, But Only For 3 Days
Though we’re well into the winter season, Lilly Pulitzer always finds a way to get us excited for spring and summer. The ...
6h
Eli Lilly and Company to set-up global capability centre in Hyderabad, to recruit over 1,000 skilled workers
The company said that it would be recruiting more than a 1,000 highly-skilled team members to strengthen its digital strategy ...
3h
Novo, Eli Lilly to dominate global pharma sales in 2025: report
Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Zepbound
Thrive Global
Liverpool
Hyderabad
Morgan Stanley
Feedback